Therapeutic delivery

Nose-applied temperature-sensitive gel for delivering α-Cyperone nanoparticles to the brain

Updated

Abstract

The optimized α-Cy-SLNs exhibited a mean particle size of 279.5 ± 0.06 nm and an entrapment efficiency of 70.0 ± 2.21%.

  • The formulation demonstrated a polydispersity index of 0.203 ± 0.24 and a zeta potential of -23.1 ± 2.38 mV, indicating favorable stability characteristics.
  • Sustained release of α-Cy from the solid lipid nanoparticles suggests potential for prolonged drug delivery.
  • Incorporation into a thermosensitive gel is associated with controlled release and enhanced bioavailability.
  • The α-Cy-SLN gel formulation may enhance bioavailability and therapeutic potential for neuroprotection in Alzheimer's disease.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free